Keosys : positive results from Phase 3 NETTER-1 Study
30 November 2015
Keosys announces positive results from Phase 3 NETTER-1 Study centralized and assessed by its Innovative Cloud based Clinical Trial Imaging Management System (CTIMS) platform and independent reading expert center.
We use cookies and third-party tracking tools to remember your preferences, to measure and analyze the use of our websites, and to optimize your experience. You can manage the use of cookies in your browser settings and withdraw your consent at any time. For more information, see our cookie management policy. You can also refuse the use of cookies.